Italy Beta Blocking Medicine Sales is set to reach $468.83 Million by 2026 from $457.93 Million 2021, jumped by 3.8% per year. Since 2017, the market increased 2.4% year on year reaching $2,480 Million. The country was number 2 in 2021, Germany came ahead $457.93 Million. Italy, Canada and Australia respectively came in numbers 2, 3 and 4 in this ranking.
How does Italy rank in Beta Blocking Medicine Sales?
| # | 7 Countries | Million US Dollars | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 Germany | 807.1 | 2023 | -0.025% | +0.62% | View data |
| 2 | 2 Italy | 418.9 | 2023 | +6.05% | +0.14% | |
| 3 | 3 Chile | 30.3 | 2023 | +3.06% | +0.54% | View data |
| 4 | 4 Finland | 21.4 | 2023 | -0.93% | -3.52% | View data |
| 5 | 5 Estonia | 6.3 | 2023 | 0% | -0.62% | View data |
